International Journal of Cardiology
Volume 152, Issue 3 , Pages 302-306 , 3 November 2011

Five-year outcomes of sirolimus-eluting versus paclitaxel-eluting stents: A propensity matched study: Clinical evidence of late catch-up?

  • Young-Guk Ko

      Affiliations

    • Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Republic of Korea
    • ,
  • Jung-Sun Kim

      Affiliations

    • Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Republic of Korea
    • ,
  • Donghoon Choi

      Affiliations

    • Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Republic of Korea
    • ,
  • Myeong-Ki Hong

      Affiliations

    • Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Republic of Korea
    • ,
  • Pil-Ki Min

      Affiliations

    • Gangnam Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea
    • ,
  • Young Won Yoon

      Affiliations

    • Gangnam Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea
    • ,
  • Bum-Kee Hong

      Affiliations

    • Gangnam Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea
    • ,
  • Byoung-Kwon Lee

      Affiliations

    • Gangnam Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea
    • ,
  • Hyuck-Moon Kwon

      Affiliations

    • Gangnam Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea
    • ,
  • Byeong-Keuk Kim

      Affiliations

    • National Health Insurance Coperation Ilsan Hospital, Goyang, Republic of Korea
    • ,
  • Sung-Jin Oh

      Affiliations

    • National Health Insurance Coperation Ilsan Hospital, Goyang, Republic of Korea
    • ,
  • Dong-Wun Jeon

      Affiliations

    • National Health Insurance Coperation Ilsan Hospital, Goyang, Republic of Korea
    • ,
  • Joo-Young Yang

      Affiliations

    • National Health Insurance Coperation Ilsan Hospital, Goyang, Republic of Korea
    • ,
  • Yangsoo Jang

      Affiliations

    • Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Republic of Korea
    • Corresponding Author InformationCorresponding author. Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System, 250 Seongsanno, Seodaemun-gu, Seoul, Republic of Korea (120-752). Tel.: +82 2 2228 8460; fax: +82 2 2227 7732.

Received 2 April 2010 ,Revised 26 May 2010 ,Accepted 4 July 2010.

References 

  1. Babapulle MN, Joseph L, Bélisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet. 2004;364:583–591
  2. Eisenberg MJ, Konnyu KJ. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis. Am J Cardiol. 2006;98:375–382
  3. Silber S. Cypher versus Taxus: are there differences?. J Interv Cardiol. 2005;18:441–446
  4. Goy JJ, Stauffer JC, Siegenthaler M, Benoît A, Seydoux C. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial. J Am Coll Cardiol. 2005;45:308–311
  5. Morice MC, Colombo A, Meier B, et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA. 2006;295:895–904
  6. Galløe AM, Thuesen L, Kelbaek H, et al. Randomized trial in everyday clinical practice: the SORT OUT II comparison of paclitaxel- and sirolimus-eluting stents. JAMA. 2008;299:409–416
  7. Dibra A, Kastrati A, Mehilli J, et al. Paclitaxel-eluting or sirolimus eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005;353:663–670
  8. Mehilli J, Dibra A, Kastrati A, et al. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J. 2006;27:260–266
  9. Kastrati A, Mehilli J, von Beckerath N, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA. 2005;293:165–171
  10. Windecker S, Remondino A, Eberli FR, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med. 2005;353:653–662
  11. Kim YH, Park SW, Lee SW, et al. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation. 2006;114:2148–2153
  12. Kaiser C, Brunner-La Rocca HP, Buser PT, et al. Incremental cost-effectiveness of drug-eluting stents compared with a third generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET). Lancet. 2005;366:921–929
  13. de Lezo J, Medina A, Pan M, et al. Randomized rapamycin versus paclitaxel CORPAL study (abstr). J Am Coll Cardiol. 2005;45(suppl):75A
  14. Cervinka P, Costa MA, Angiolillo DJ, et al. Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study. Catheter Cardiovasc Interv. 2006;67:846–851
  15. Simonton CA, Brodie B, Cheek B, et al. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry–STENT Group. J Am Coll Cardiol. 2007;50:1214–1222
  16. Sidhu S, Shafiq N, Malhotra S, Pandhi P, Grover A. A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease. Br J Clin Pharmacol. 2006;61:720–726
  17. Kastrati A, Dibra A, Eberle S, et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA. 2005;294:819–825
  18. Schömig A, Dibra A, Windecker S, et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol. 2007;50:1373–1380
  19. Gurm HS, Boyden T, Welch KB. Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis. Am Heart J. 2008;155:630–639
  20. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007;370:937–948
  21. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020–1029
  22. Teirstein PS, Massullo V, Jani S, et al. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation. 2000;101:360–365
  23. Waksman R, Ajani AE, White RL, et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation. 2004;109:340–344
  24. Costa MA, Sabaté M, van der Giessen WJ, et al. Late coronary occlusion after intracoronary brachytherapy. Circulation. 1999;100:789–792
  25. Carter AJ, Aggarwal M, Kopia GA, et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res. 2004;63:617–624
  26. Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation. 2001;104:473–479
  27. Park DW, Hong MK, Mintz GS, et al. Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late “catch-up” phenomenon from ASPECT Study. J Am Coll Cardiol. 2006;48:2432–2439
  28. Tsuchida K, Serruys PW, Bruining N, et al. Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial. Am J Cardiol. 2007;99:607–615
  29. Sousa JE, Costa MA, Abizaid A, et al. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation. 2005;111:2326–2329
  30. Wilson GJ, Nakazawa G, Schwartz RS, et al. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation. 2009;120:141–149
  31. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

PII: S0167-5273(10)00550-4

doi: 10.1016/j.ijcard.2010.07.023

International Journal of Cardiology
Volume 152, Issue 3 , Pages 302-306 , 3 November 2011

Article Tools

* Image Usage & Resolution